2009
DOI: 10.2174/138161209789271834
|View full text |Cite
|
Sign up to set email alerts
|

Angiotensin Converting Enzyme (ACE) Inhibitory Peptides: Production and Implementation of Functional Food

Abstract: In recent decades, the most successful strategy for controlling blood pressure has been inhibition of the angiotensin-converting enzyme (ACE). ACE inhibitors of chemical synthesis (captopril, enalapril, ramipril and trandolapril) have been widely used clinically to reduce mortality in patients with heart failure, and in patients with recent myocardial infarction and heart failure or marked left ventricular dysfunction. In addition to preventive and therapeutic drugs, increased attention has been paid to identi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
44
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 126 publications
(46 citation statements)
references
References 197 publications
(224 reference statements)
2
44
0
Order By: Relevance
“…Angiotensin-converting enzyme inhibitory peptides exist in plant proteins such that soy can be enzymatically released from precursor proteins. These peptides can reduce blood pressure by decreasing the vasoconstrictory effects of angiotensin II and enhancing the vasodilatory effects of bradykinin [35]. Our study has strengths as well as limitations.…”
Section: Discussionmentioning
confidence: 99%
“…Angiotensin-converting enzyme inhibitory peptides exist in plant proteins such that soy can be enzymatically released from precursor proteins. These peptides can reduce blood pressure by decreasing the vasoconstrictory effects of angiotensin II and enhancing the vasodilatory effects of bradykinin [35]. Our study has strengths as well as limitations.…”
Section: Discussionmentioning
confidence: 99%
“…It is not clear how SP alters eicosanoid production or whether SP alters disease via another mechanism that resulted in eicosanoids being restored to levels similar to normal. A plausible mechanism may be via the bioactive peptides produced via digestion of the proteins, which have been reported to alter the renin–angiotensin system, which mediates its effects via changes in prostanoid levels as well as being itself regulated by COX products . The SP effects may be similar to low protein effects on kidneys, as dietary protein level also affects renal eicosanoids via an unexplained mechanism .…”
Section: Discussionmentioning
confidence: 99%
“…ACE (EC 3.4.15.1) is a hypertension‐responsible glycoprotein present both in biological fluids and many tissues (Guang and Philips ). The 3‐dimensional structure of this glycoprotein shows that ACE is a zinc metallopeptidase (De Leo and others ) which can adopt 2 different forms: somatic and testicular (Ni and others ). In recent years, a 3rd form of ACE was identified, defined as homolog ACE (ACEH) (Meisel and others ).…”
Section: Ace and Its Role In Hypertensionmentioning
confidence: 99%
“…The identification of specific molecular properties which determine a peptide's biological activity can be an attribute considered in the production of nutraceuticals and functional foods (Dziuba and others ). Peptides known as ACE inhibitors belong to a group called “bioactive substances” (De Leo and others ). In food science, to be considered as a “bioactive substance” the analyzed compound must meet 2 criteria: (a) apart from the defined nutritional value of food product, an active substance encrypted in it has to show a measurable biological effect after excessive consumption; (b) the biological effect must be beneficial for health (Möller and others ).…”
Section: Food Peptides With An Ace Inhibitory Activity—their Structurmentioning
confidence: 99%